Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis

Arthritis and Rheumatology

Volumn 68, Issue 3, 2016, Pages 679-689

  Gracey, Eric ^a   Yao, Yuchen ^a   Green, Blerta ^a   Qaiyum, Zoya ^a   Baglaenko, Yuriy ^a   Lin, Aifeng ^a   Anton, Ammepa ^a   Ayearst, Renise ^a   Yip, Paul ^a   Inman, Robert D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA; INTERFERON GAMMA (1-39); PEPTIDE FRAGMENT;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TH1 CELL; TH17 CELL; UNFOLDED PROTEIN RESPONSE; UPREGULATION; BLOOD; IMMUNOLOGY; MICROARRAY ANALYSIS; PATHOLOGY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICROARRAY ANALYSIS; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SEX FACTORS; SPONDYLITIS, ANKYLOSING; TH1 CELLS; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84963827869     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39464     Document Type: Article

References (40)

1. Braun J, Sieper J., Ankylosing spondylitis. Lancet 2007; 369: 1379-90.
2. Appel H, Kuhne M, Spiekermann S, Ebhardt H, Grozdanovic Z, Kohler D, et al., Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54: 2845-51.
3. Van der Horst-Bruinsma IE, Zack DJ, Szumski A, Koenig AS., Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies. Ann Rheum Dis 2013; 72: 1221-4.
4. Gran JT, Husby G., Ankylosing spondylitis in women. Semin Arthritis Rheum 1990; 19: 303-12.
5. Lee W, Reveille JD, Davis JC Jr, Learch TJ, Ward MM, Weisman MH., Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2007; 66: 633-8.
6. Cua DJ, Tato CM., Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10: 479-89.
7. Shen H, Goodall JC, Hill Gaston JS., Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009; 60: 1647-56.
8. + cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 2011; 13: R95.
9. Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al., Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 2013; 45: 730-8.
10. Danska JS., Sex matters for mechanism. Sci Transl Med 2014; 6: 258fs40.
11. Oertelt-Prigione S., The influence of sex and gender on the immune response. Autoimmun Rev 2012; 11: A479-85.
12. Zhang MA, Rego D, Moshkova M, Kebir H, Chruscinski A, Nguyen H, et al., Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci U S A 2012; 109: 9505-10.
13. Van der Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
14. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A., A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-91.
15. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA., HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60: 2633-43.
16. Zeng L, Lindstrom MJ, Smith JA., Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum 2011; 63: 3807-17.
17. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, et al., Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci U S A 2010; 107: 17698-703.
18. Jansen R, Batista S, Brooks AI, Tischfield JA, Willemsen G, van Grootheest G, et al., Sex differences in the human peripheral blood transcriptome. BMC Genomics 2014; 15: 33.
19. Huang WN, Tso TK, Kuo YC, Tsay GJ., Distinct impacts of syndesmophyte formation on male and female patients with ankylosing spondylitis. Int J Rheum Dis 2012; 15: 163-8.
20. Gracey E, Haroon N, Inman RD., HLA-B27, cytokines, and spondyloarthritis: noncanonical functions of a curious class I major histocompatibility complex gene [editorial]. Arthritis Rheumatol 2014; 66: 783-5.
21. Fert I, Cagnard N, Glatigny S, Letourneur F, Jacques S, Smith JA, et al., Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis. Arthritis Rheumatol 2014; 66: 841-51.
22. Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA., Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-γ dysregulation. Arthritis Rheum 2008; 58: 1640-9.
23. Wendling D, Cedoz JP, Racadot E, Dumoulin G., Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 2007; 74: 304-5.
24. Pollinger B, Junt T, Metzler B, Walker UA, Tyndall A, Allard C, et al., Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol 2011; 186: 2602-12.
25. Kikuta J, Wada Y, Kowada T, Wang Z, Sun-Wada GH, Nishiyama I, et al., Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest 2013; 123: 866-73.
26. Pimentel-Santos FM, Ligeiro D, Matos M, Mourao AF, Costa J, Santos H, et al., Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther 2011; 13: R57.
27. Gu J, Wei YL, Wei JC, Huang F, Jan MS, Centola M, et al., Identification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction. Arthritis Rheum 2009; 60: 3269-79.
28. Sharma SM, Choi D, Planck SR, Harrington CA, Austin CR, Lewis JA, et al., Insights into the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther 2009; 11: R168.
29. Duan R, Leo P, Bradbury L, Brown MA, Thomas G., Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann Rheum Dis 2010; 69: 1724-9.
30. Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, et al., Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 2011; 186: 2672-80.
31. Zou T, Satake A, Corbo-Rodgers E, Schmidt AM, Farrar MA, Maltzman JS, et al., IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo. J Immunol 2012; 189: 28-32.
32. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al., Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-60.
33. Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S, Akizuki S, et al., Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 2010; 207: 1135-43.
34. Martinez FO., The transcriptome of human monocyte subsets begins to emerge. J Biol 2009; 8: 99.
35. Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC., Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 2011; 208: 251-60.
36. Surdacki A, Sulicka J, Korkosz M, Mikoaljczyk T, Telesinska-Jasiowka D, Klimek E, et al., Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis. J Rheumatol 2014; 41: 481-9.
37. Cheung PF, Wong CK, Lam CW., Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 2008; 180: 5625-35.
38. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al., Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203: 2673-82.
39. Wallis D, Inman RD., Recognition of preclinical and early disease in axial spondyloarthritis. Rheum Dis Clin North Am 2014; 40: 685-97.
40. Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, et al., Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 2013; 382: 1705-13.